Dysregulation of the basal RNA polymerase transcription apparatus in cancer
-
Altmetric Citations
Bywater, Megan J.; Pearson, Richard B.; McArthur, Grant A.; Hannan, Ross D.
Description
Mutations that directly affect transcription by RNA polymerases rank among the most central mediators of malignant transformation, but the frequency of new anticancer drugs that selectively target defective transcription apparatus entering the clinic has been limited. This is because targeting the large protein-protein and protein-DNA interfaces that control both generic and selective aspects of RNA polymerase transcription has proved extremely difficult. However, recent technological advances...[Show more]
dc.contributor.author | Bywater, Megan J. | |
---|---|---|
dc.contributor.author | Pearson, Richard B. | |
dc.contributor.author | McArthur, Grant A. | |
dc.contributor.author | Hannan, Ross D. | |
dc.date.accessioned | 2016-02-04T23:24:14Z | |
dc.date.available | 2016-02-04T23:24:14Z | |
dc.identifier.issn | 1474-175X | |
dc.identifier.uri | http://hdl.handle.net/1885/97925 | |
dc.description.abstract | Mutations that directly affect transcription by RNA polymerases rank among the most central mediators of malignant transformation, but the frequency of new anticancer drugs that selectively target defective transcription apparatus entering the clinic has been limited. This is because targeting the large protein-protein and protein-DNA interfaces that control both generic and selective aspects of RNA polymerase transcription has proved extremely difficult. However, recent technological advances have led to a 'quantum leap' in our comprehension of the structure and function of the core RNA polymerase components, how they are dysregulated in a broad range of cancers and how they may be targeted for 'transcription therapy'. | |
dc.description.sponsorship | This work was supported by the National Health and Medical Research Council (NHMRC) of Australia programme and project grants; Leukemia Foundation Grant in Aid; Prostate Cancer Foundation of Australia grant in aid; NHMRC Research Fellowship to R.D.H. and R.B.P.; NHMRC Postgraduate Research Scholarship, GSK Postgraduate Research Scholarship and Leukemia Foundation Postdoctoral Fellowship to M.J.B.; Cancer Council of Victoria Sir Edward Weary Dunlop Clinical Research Fellowship and NHMRC Clinical Research Fellowship to G.A.M. | |
dc.publisher | Nature Publishing Group | |
dc.rights | © 2013 Macmillan Publishers Limited. | |
dc.source | Nature Reviews Cancer | |
dc.subject | animals | |
dc.subject | antineoplastic agents | |
dc.subject | cell transformation, neoplastic | |
dc.subject | dna-directed rna polymerases | |
dc.subject | gene expression regulation, neoplastic | |
dc.subject | humans | |
dc.subject | molecular targeted therapy | |
dc.subject | mutation | |
dc.subject | neoplasms | |
dc.subject | oncogenes | |
dc.subject | transcription factors, general | |
dc.subject | transcriptional activation | |
dc.title | Dysregulation of the basal RNA polymerase transcription apparatus in cancer | |
dc.type | Journal article | |
local.description.notes | At the time of publication the author Hannan was affiliated with Peter MacCallum Cancer Centre, Research, Melbourne Victoria, Australia. | |
local.identifier.citationvolume | 13 | |
dc.date.issued | 2013-05 | |
local.publisher.url | http://www.nature.com/index.html | |
local.type.status | Published Version | |
local.contributor.affiliation | Hannan, R., John Curtin School of Medical Research, The Australian National University | |
local.identifier.essn | 1474-1768 | |
local.bibliographicCitation.issue | 5 | |
local.bibliographicCitation.startpage | 299 | |
local.bibliographicCitation.lastpage | 314 | |
local.identifier.doi | 10.1038/nrc3496 | |
Collections | ANU Research Publications |
Download
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.
Updated: 17 November 2022/ Responsible Officer: University Librarian/ Page Contact: Library Systems & Web Coordinator